GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Total Equity

Belluscura (FRA:9VQ) Total Equity : €23.26 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Total Equity?

Belluscura's total equity for the quarter that ended in Jun. 2023 was €23.26 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Belluscura Total Equity Historical Data

The historical data trend for Belluscura's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Total Equity Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Total Equity
2.02 3.36 3.84 21.84 19.21

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Equity Get a 7-Day Free Trial Premium Member Only 23.25 21.84 22.51 19.21 23.26

Belluscura Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Belluscura's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=22.277-3.064
=19.21

Belluscura's Total Equity for the quarter that ended in Jun. 2023 is calculated as

Total Equity=Total Assets(Q: Jun. 2023 )-Total Liabilities(Q: Jun. 2023 )
=25.086-1.826
=23.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura Total Equity Related Terms

Thank you for viewing the detailed overview of Belluscura's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Total Equity
Comparable Companies
LSE:IUG LSE:IHC LSE:POLX LSE:SUN LSE:MHC LSE:DEMG LSE:RUA LSE:CREO LSE:EKF ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN
Traded in Other Exchanges
BELL:UK
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Website
https://www.belluscura.com
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines